Inventor
ISHIWATA YOSHIRO
JP21 patents
⚠️ This page may combine multiple inventors who share the name “ISHIWATA YOSHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANWA KAGAKU KENKYUSHO CO
11 patentsUS6962926B2Nov 8, 2005
Antagonist of MCP-1 function, and compositions and methods of use thereof
SANWA KAGAKU KENKYUSHO CO17 citations81
US5340806AAug 23, 1994
Composition containing organogermanium compound and immunity adjusting agent comprising the composition
SANWA KAGAKU KENKYUSHO CO11 citations74
US4889715ADec 26, 1989
Composition containing organogermanium compound and immunity adjusting agent comprising the composition
SANWA KAGAKU KENKYUSHO CO13 citations74
US5730971AMar 24, 1998
Potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator
SANWA KAGAKU KENKYUSHO CO6 citations70
US5356880AOct 18, 1994
Glycyrrhetinic acid derivatives
SANWA KAGAKU KENKYUSHO CO10 citations70
US5560925AOct 1, 1996
Method of treating wart
SANWA KAGAKU KENKYUSHO CO3 citations62
US6998407B2Feb 14, 2006
Antagonists of MCP-1 function and methods of use thereof
SANWA KAGAKU KENKYUSHO CO2 citations61
US5279835AJan 18, 1994
Binder-free orally administrable tablet containing 3-oxygermylpropionic acid
SANWA KAGAKU KENKYUSHO CO4 citations61
US5336688AAug 9, 1994
Composition containing organogermanium compound and immunity adjusting agents comprising the compositions
SANWA KAGAKU KENKYUSHO CO4 citations60
US5260056ANov 9, 1993
Composition for enhancing biosynthesis of interferon
SANWA KAGAKU KENKYUSHO CO3 citations57
US5621003AApr 15, 1997
Maillard reaction inhibitor
SANWA KAGAKU KENKYUSHO CO1 citations52
TELIK INC
5 patentsUS7297696B2Nov 20, 2007
Antagonists of MCP-1 function and methods of use thereof
TELIK INC18 citations91
US6670364B2Dec 30, 2003
Antagonists of MCP-1 function and methods of use thereof
TELIK INC14 citations82
US6809113B2Oct 26, 2004
Antagonists of MCP-1 function and methods of use thereof
TELIK INC8 citations72
US6677365B2Jan 13, 2004
Antagonists of MCP-1 function and methods of use thereof
TELIK INC11 citations72
US6992086B2Jan 31, 2006
Antagonists of MCP-1 function and methods of use thereof
TELIK INC1 citations51
UNIV TOKYO
3 patentsUS11572393B2Feb 7, 2023
HMGN partial peptide and cancer therapy using the same
UNIV TOKYO2 citations70
US10746726B2Aug 18, 2020
Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
UNIV TOKYO1 citations61
US11919932B2Mar 5, 2024
HMGN partial peptide and cancer therapy using the same
UNIV TOKYO0 citations59